Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-12-08

FDA Approved: KANUMA — Original Application (Alexion Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Kanuma (sebelipase alfa) from Alexion Pharmaceuticals as the original approval for the treatment of lysosomal acid lipase deficiency. This mark…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KANUMA (Sebelipase alfa)

Snippet

ORIG AP for KANUMA (SEBELIPASE ALFA)